Get the Stockscreener App
0.665
1.04%
0.0207
Tela Bio Inc stock is traded at $0.665, with a volume of 194.72K.
It is up +1.04% in the last 24 hours and down -10.94% over the past month.
TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
See More
Previous Close:
$0.6443
Open:
$0.64
24h Volume:
194.72K
Relative Volume:
1.69
Market Cap:
$29.23M
Revenue:
$80.28M
Net Income/Loss:
$-38.83M
P/E Ratio:
-0.7995
EPS:
-0.8318
Net Cash Flow:
$-28.67M
1W Performance:
-30.00%
1M Performance:
-10.94%
6M Performance:
-14.98%
1Y Performance:
-58.80%
1-Day Range:
$0.622
$0.6913
1-Week Range:
$0.622
$0.90
52-Week Range:
$0.5011
$2.00
Tela Bio Inc Stock (TELA) Company Profile
Name
Tela Bio Inc
Sector
Industry
Phone
484-320-2930
Address
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Compare TELA vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
0.651 | 28.93M | 80.28M | -38.83M | -28.67M | -0.8318 |
ABT
Abbott Laboratories
|
109.67 | 192.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
331.73 | 130.11B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
90.54 | 116.83B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.48 | 75.11B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.67 | 52.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-21-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-31-22 | Initiated | Lake Street | Buy |
| Dec-03-19 | Initiated | Canaccord Genuity | Buy |
| Dec-03-19 | Initiated | JMP Securities | Mkt Outperform |
| Dec-03-19 | Initiated | Jefferies | Buy |
| Dec-03-19 | Initiated | Piper Jaffray | Overweight |
View All
Tela Bio Inc Stock (TELA) Latest News
Tela Bio Earnings Call: Growth Meets Execution Risks - TipRanks
TELA Bio (TELA) stake: Nantahala group reports 12.94% ownership of 5.79M shares - Stock Titan
TELA BIO (TELA): SilverArc Capital and Devesh Gandhi disclose 2.14M-share 4.8% stake - Stock Titan
Analysts Have Been Trimming Their TELA Bio, Inc. (NASDAQ:TELA) Price Target After Its Latest Report - simplywall.st
TELA Bio, Inc. Revenue Breakdown – BOATS:TELA - TradingView
TELA Bio, Inc. 2026: Revenue $19.29M, EPS ($0.2) — 10-Q Summary - TradingView
TELA Bio (NASDAQ: TELA) faces going concern doubt amid debt covenants and cash burn - Stock Titan
TELA Bio loss hits USD 9.3M in Q2 2026 - Medical Buyer
TELA BIO (TELA): SilverArc and Devesh Gandhi report 4.8% ownership stake - Stock Titan
TELA Bio, Inc. Stock 12‑Month Price Target Cut to $2.1, Implies 126% Upside - TradingView
Tela Bio earnings missed by $0.03, revenue fell short of estimates - Investing.com Canada
TELA Bio Inc (TELA) (Q2 2026) Earnings Call Highlights: Navigati - GuruFocus
TELA Bio Inc (TELA) (Q2 2026) Earnings Call Highlights: Navigating PRS Headwinds and Strategic ... - Yahoo Finance
TELA Bio, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
TELA Looks 43.6% Undervalued on GF Value™ Despite Operational Un - GuruFocus
Transcript : TELA Bio, Inc., Q2 2026 Earnings Call, Aug 10, 2026 - marketscreener.com
TELA Bio misses Q2 revenue, withdraws full-year guidance - scanx.trade
TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
TELA Bio Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings call transcript: TELA Bio misses Q2 2026 estimates, withdraws guidance - Investing.com
Is TELA Bio Inc (TELA) Positioned for Recovery After Q2 Earnings Miss? GF Score: 57/100 - GuruFocus
Q2 2026 TELA Bio Inc Earnings Call Transcript - GuruFocus
TELA Bio Q2 revenue falls on lower OviTex PRS volumes, withdraws outlook - TradingView
TELA Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
TELA Bio Reports Second Quarter 2026 Financial Results - The Manila Times
BRIEF-TELA Bio Q2 Revenue USD 19.291 Million Vs. IBES Estimate USD 20 Million - TradingView
TELA Bio Withdraws 2026 Revenue Guidance as Sales Fall 4% - Stock Titan
TELA Bio (TELA) Earnings Date and Reports 2026 $TELA - marketbeat.com
TELA Bio Inc (TELA) Stock Analysis & Forecast - TradingKey
TELA Bio Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView
TELA Bio Inc (TELA) Stock News Today - TradingKey
TELA Bio Inc (TELA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
People on the Move: Heather Getz Joins TELA Bio as Chief Executive Officer - BioBuzz
Earnings To Watch: TELA Bio Inc (TELA) Q2 2026 -- GF Value Sees 97% Upside - Yahoo Finance
TELA Q2'26 Earnings: EPS estimate is (0.17) USD - TradingView
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - marketscreener.com
Large equity grants for TELA Bio, Inc. (TELA) CEO Heather Getz - Stock Titan
TELA Bio, Inc. (TELA) CEO discloses 5,000-share ownership stake - Stock Titan
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
TELA Bio’s New CEO and 11 New Hires Get Stock Grants - Stock Titan
TELA Bio appoints Heather Getz as new CEO - The Globe and Mail
TELA Bio appoints Heather Getz as chief executive officer By Investing.com - Investing.com Australia
Earnings Preview: TELA Bio to Report Financial Results Post-market on August 10 - moomoo.com
TELA Bio appoints Heather Getz as chief executive officer - Investing.com
TELA Bio Appoints Heather Getz as Chief Executive Officer and Director - Quiver Quantitative
Heather Getz named CEO of TELA Bio as Antony Koblish exits - TradingView
TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director - Yahoo Finance
TELA Q2'26 Earnings: revenue estimate is 20.01M USD - TradingView
TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference - The Manila Times
TELA|TELA Bio Inc|Price:0.644|Chg%:-0.034 - TradingKey
TELA Bio Sets Aug. 10 Earnings Call and Business Update - MyChesCo
Tela Bio Inc Stock (TELA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):